|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.83 CNY | +2.85% |
|
+1.31% | +7.23% |
| 02-25 | Shyndec Pharmaceutical Gets China Approval for Antidepressant | MT |
| 02-12 | Shyndec Pharmaceutical Secures Bids For 51 Drugs in China's Latest Procurement Program | MT |
| Capitalization | 13.55B 1.96B 1.69B 1.53B 1.47B 2.67B 181B 2.8B 18.07B 7.24B 86.56B 7.37B 7.21B 310B | P/E ratio 2023 |
18x | P/E ratio 2024 | 14.8x |
|---|---|---|---|---|---|
| Enterprise value | 7.04B 1.02B 880M 795M 762M 1.39B 93.82B 1.45B 9.39B 3.76B 44.99B 3.83B 3.75B 161B | EV / Sales 2023 |
0.69x | EV / Sales 2024 | 0.87x |
| Free-Float |
41.74% | Yield 2023 |
1.02% | Yield 2024 | 2.51% |
| 1 day | +2.85% | ||
| 1 week | +1.31% | ||
| Current month | +1.31% | ||
| 1 month | +1.03% | ||
| 3 months | +4.84% | ||
| 6 months | -4.41% | ||
| Current year | +7.23% |
| 1 week | 10.49 |  | 11.05 |
| 1 month | 10.49 | | 11.05 |
| Current year | 10.1 | | 11.05 |
| 1 year | 9.69 | | 11.8 |
| 3 years | 7.61 | | 14.41 |
| 5 years | 7.61 | | 14.41 |
| 10 years | 7.61 | | 18.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jing Zu
DFI | Director of Finance/CFO | 56 | - |
Qian Yin Jing
IRC | Investor Relations Contact | 46 | 2019-09-12 |
Zhong Xi Zhang
SEC | Corporate Secretary | 50 | 2024-03-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiang Dong Yu
BRD | Director/Board Member | 62 | 2019-01-30 |
Peng Wang
BRD | Director/Board Member | 44 | 2022-11-27 |
Yong Liu
BRD | Director/Board Member | 57 | 2021-05-16 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.85% | +1.31% | -3.56% | +3.93% | 2.11B | |
| -2.69% | -14.15% | -18.71% | -37.87% | 55.54B | |
| +0.01% | -3.11% | +10.48% | +55.23% | 7.95B | |
| +4.04% | -21.96% | +1.30% | -21.69% | 7.48B | |
| -3.47% | -14.11% | -3.74% | +56.62% | 5.43B | |
| +0.51% | -9.89% | -16.48% | +95.62% | 4.97B | |
| -0.74% | -1.57% | +67.98% | +40.43% | 3.1B | |
| +4.04% | -4.33% | -18.17% | -19.76% | 2.68B | |
| -2.72% | -11.59% | +329.90% | +674.13% | 2.56B | |
| +1.59% | -2.38% | +41.63% | +54.29% | 2.54B | |
| Average | +0.34% | -7.06% | +39.06% | +90.09% | 9.44B | |
| Weighted average by Cap. | -1.31% | -9.50% | +0.59% | +9.53% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 12.07B 1.75B 1.51B 1.36B 1.31B 2.38B 161B 2.49B 16.1B 6.45B 77.13B 6.57B 6.43B 276B | 10.94B 1.59B 1.37B 1.23B 1.18B 2.16B 146B 2.26B 14.59B 5.85B 69.89B 5.95B 5.83B 250B |
| Net income | 692M 100M 86.5M 78.08M 74.92M 137M 9.22B 143M 923M 370M 4.42B 377M 368M 15.81B | 1.08B 157M 135M 122M 117M 214M 14.44B 224M 1.45B 579M 6.92B 590M 577M 24.77B |
| Net Debt | -4.83B -700M -604M -545M -523M -953M -64.34B -998M -6.44B -2.58B -30.85B -2.63B -2.57B -110B | -6.51B -943M -813M -734M -704M -1.28B -86.69B -1.34B -8.68B -3.48B -41.57B -3.54B -3.46B -149B |
Employees
11,472
Sector
Pharmaceuticals
Calendar
03-28 -
Earnings release - Annual 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-06 | 10.83 ¥ | +2.85% | 18,241,280 |
| 26-03-05 | 10.53 ¥ | -0.28% | 14,023,500 |
| 26-03-04 | 10.56 ¥ | -2.49% | 15,477,600 |
| 26-03-03 | 10.83 ¥ | +0.93% | 23,653,590 |
| 26-03-02 | 10.73 ¥ | +0.37% | 14,286,470 |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600420 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition